Scott Kellen
2018
In 2018, Scott Kellen earned a total compensation of $642.9K as Chief Financial Officer and Secretary at DiaMedica Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $70,200 |
|---|---|
| Option Awards | $361,957 |
| Salary | $200,833 |
| Other | $9,931 |
| Total | $642,921 |
Kellen received $362K in option awards, accounting for 56% of the total pay in 2018.
Kellen also received $70.2K in non-equity incentive plan, $200.8K in salary and $9.9K in other compensation.
Rankings
In 2018, Scott Kellen's compensation ranked 11,030th out of 14,244 executives tracked by ExecPay. In other words, Kellen earned more than 22.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,030 out of 14,244 | 23rd |
Division Manufacturing | 4,442 out of 5,765 | 23rd |
Major group Chemicals And Allied Products | 1,685 out of 2,128 | 21st |
Industry group Drugs | 1,430 out of 1,817 | 21st |
Industry Pharmaceutical Preparations | 1,098 out of 1,391 | 21st |
Source: SEC filing on April 8, 2019.
Kellen's colleagues
We found two more compensation records of executives who worked with Scott Kellen at DiaMedica Therapeutics in 2018.
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019